~~<i id='69E4B1F419'><strike id='69E4B1F419'><tt id='69E4B1F419'><pre id='69E4B1F419'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

comprehensive

author：leisure time 2025-10-01 05:39:02 - browse：54184

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： STAT Virtual Event: Putting AI to the Test

hotspot

focus

explore

hotspot

0:37CanadianPrimeministerJustinTrudeauandwifeSophieTrudeauinLondon,May6,2023.JacobKing-PaImages/PAIm

WSS

Senate HELP committee spars over health care workforce policies

Senate HELP committee spars over health care workforce policies

No plane should take off without an EpiPen onboard

Second xenotransplant done with gene

Emergency workers more likely to restrain Black patients: study

5 important ways Henrietta Lacks changed medical science

entertainment

comprehensive

hotspot

Cancer drug shortages should be causing more outrage

Physician groups backed by private equity giant lobby on mergers

Sports medicine is finally prioritizing gender equality

Hearing on Medicare drug price negotiation gets unusually heated

Guidelines to prevent youth baseball injuries need more muscle

‘Oppenheimer’ and the risks of AI in health care

In Memoriam: Notable people who died in 2023

What to expect as Trump is arraigned on his Jan 6. indictment

In Memoriam: Notable people who died in 2023

Wildfire pollution widens asthma inequities on Long Island

focus

Physician groups backed by private equity giant lobby on mergers

Physician groups backed by private equity giant lobby on mergers

Microbiome research is starting to find links to chronic diseases

National panel will explore requiring free Covid tests

Senate HELP committee spars over health care workforce policies

National panel will explore requiring free Covid tests

focus

focus

explore

hotspot